FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

8941001000001100: Not available (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40299001000001111 Not available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40299101000001112 Not available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Not available Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Polyfusor LG glucose 5% / lidocaine 2g/500ml (0.4%) solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vamin 9 Glucose solution for injection 100ml bottles (Fresenius Kabi Ltd) 1 bottle VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vamin 9 Glucose solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Clonazepam 500micrograms/5ml oral solution (Special Order) 1 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Goddard's Embrocation (Actavis UK Ltd) 200 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Zubes Honey & Lemon lozenges (Ernest Jackson & Co. Ltd) 36 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Glamin solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Throaties Blackcurrant pastilles (Ernest Jackson & Co. Ltd) 10 pastille VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Clonazepam 500micrograms/5ml oral solution (Drug Tariff Special Order) 150 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vamin 9 Glucose solution for injection 1litre bottles (Fresenius Kabi Ltd) 1 bottle VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Polyfusor LG glucose 5% / lidocaine 2g/500ml (0.4%) solution for injection 500ml bottles (Fresenius Kabi Ltd) 12 bottle VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 40 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 80 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Testosterone propionate 50mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Furosemide 20mg/2ml solution for injection vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets 56 tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets 56 tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 20mg tablets (Amdipharm) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Oxprenolol 80mg tablets 56 tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Oxprenolol 80mg tablets 40 tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 80mg tablets (Stephar (U.K.) Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 80mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 80mg tablets (Amdipharm) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 40mg tablets (Amdipharm) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules 10 ampoule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Furosemide 20mg/2ml solution for injection vials 10 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Furosemide 20mg/2ml solution for injection vials (Wockhardt UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Virormone 100mg/2ml solution for injection ampoules (Nordic Pharma) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 80mg tablets (Sigma Pharmaceuticals Plc) 40 tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 80mg tablets (Stephar (U.K.) Ltd) 40 tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Virormone 100mg/2ml solution for injection ampoules (Nordic Pharma) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 80mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 40mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trasicor 20mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Furosemide 20mg/2ml solution for injection vials (Wockhardt UK Ltd) 10 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Bacitracin 500units/g eye ointment VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Polyfax ophthalmic ointment (Pliva Pharma Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Bacitracin 500units/g eye ointment 4 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Polyfax ophthalmic ointment (Pliva Pharma Ltd) 4 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Metabolic Mineral Mixture powder VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Hydrogel sheet with adhesive border 15cm x 13cm sacral VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Lacosamide 15mg/ml oral solution sugar free VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Isotretinoin 20mg tablets VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Drotrecogin alfa 5mg powder for solution for injection vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Isotretinoin 20mg tablets 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Hydrogel sheet with adhesive border 15cm x 13cm sacral 10 dressing VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Generic Metabolic Mineral Mixture powder 100 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Xigris 5mg powder for solution for injection vials (Eli Lilly & Co Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Drotrecogin alfa 20mg powder for solution for injection vials 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Lacosamide 15mg/ml oral solution sugar free 200 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Metabolic Mineral Mixture powder (SHS International Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vimpat 15mg/ml syrup (UCB Pharma Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Isotretinoin 20mg tablets (Sandoz Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Hydrogel sheet with adhesive border 15cm x 13cm sacral 1 dressing VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Mesitran Border sheet 15cm x 13cm sacral (Medlock Medical) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Mesitran Border sheet 15cm x 13cm sacral (Medlock Medical) 1 dressing VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Isotretinoin 20mg tablets (Sandoz Ltd) 30 tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Xigris 20mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Metabolic Mineral Mixture powder (SHS International Ltd) 100 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Xigris 5mg powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Vimpat 15mg/ml syrup (UCB Pharma Ltd) 200 ml VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Mesitran Border sheet 15cm x 13cm sacral (Medlock Medical) 10 dressing VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 40 milligram/1 gram conventional release eye gel VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Timolol 0.1% liquid eye gel VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Macrogol compound oral powder 13.8g sachets NPF VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Pilogel 4% eye gel (Alcon Eye Care UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Laxido Orange oral powder 13.8g sachets (Galen Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nyogel 0.1% eye gel (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nyogel 0.1% eye gel (Alcon Eye Care UK Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Pilocarpine hydrochloride 4% eye gel 5 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nyogel 0.1% eye gel (Waymade Healthcare Plc) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Macrogol compound oral powder 13.8g sachets NPF 30 sachet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Macrogol compound oral powder 13.8g sachets NPF 20 sachet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Timolol 0.1% gel eye drops 5 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Laxido Orange oral powder 13.8g sachets (Galen Ltd) 30 sachet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Pilogel 4% eye gel (Alcon Eye Care UK Ltd) 5 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Laxido Orange oral powder 13.8g sachets (Galen Ltd) 20 sachet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nyogel 0.1% eye gel (Alcon Eye Care UK Ltd) 5 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nyogel 0.1% eye gel (Sigma Pharmaceuticals Plc) 5 gram VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely trilostane 120 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely trilostane 60 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trilostane 120mg capsules 100 capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free 200 ml VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Modrenal 60mg capsules (Wanskerne Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Modrenal 120mg capsules (Wanskerne Ltd) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
MagnaPhate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution (Arjun Products Ltd) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free (Special Order) VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free 1 ml VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Trilostane 60mg capsules 100 capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Modrenal 60mg capsules (Wanskerne Ltd) 100 capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Modrenal 120mg capsules (Wanskerne Ltd) 100 capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free (Special Order) 1 ml VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
MagnaPhate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution (Arjun Products Ltd) 200 ml VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely aluminium hydroxide 500 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely methionine 250 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier

Start Previous Page 181 of 304 Next End

This concept is not in any reference sets

Back to Start